| Description | Dacuronium is a new steroidal drug of neuromuscular blocking properties. Dacuronium produced a competitive type of neuromuscular block with a potency of approximately one-tenth that of tubocurarine and one-fiftieth that of pancuronium. |
| Synonyms | UNII-VD6L56ZVX1, 17-Hydroxypancuronium, Androstane, piperidinium deriv |
| molecular weight | 530.83 |
| Molecular formula | C33H58N2O3 |
| CAS | 43021-45-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Baden JM. Anticholinergic actions of steroid muscle relaxants. Anaesthesia. 1976 Mar;31(2):215-8. PubMed PMID: 937668. 2. Koo YA, Lee B, Park HJ, Choi J, Lee E, Choi D. Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles. Fertil Steril. 2009 Mar;91(3):744-8. doi: 10.1016/j.fertnstert.2007.12.068. Epub 2008 Mar 5. PubMed PMID: 18321491. 3. Rechberger T, Baranowski W, Bogusiewicz M, Postawski K, Jakimiuk AJ, Tomaszewski J, Kulik-Rechberger B, Jakowicki JA. Serum concentrations of markers of type I collagen metabolism in women taking monophasic oral contraceptives. Ginekol Pol. 2002 Feb;73(2):81-6. PubMed PMID: 12001776. 4. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008 Aug;90(2):395-400. Epub 2007 Oct 24. PubMed PMID: 17919608. |